Evidence map›Paper›PMID 41562022›Full record

ReviewAntimicrobial stewardship & healthcare epidemiology : ASHE2026

A bundle of the top 10 OPAT publications in 2024.

Lindsey M Childs-Kean, Sara F Azimi, Alison M Beieler, Laila Castellino, Sara C Keller, Margaret Pertzborn, Alexandra Yamshchikov, Leah H Yoke, Kathleen Young, Monica V Mahoney

Abstract readReview
In one paragraph

Review in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lindsey M Childs-KeanDepartment of Pharmacy Education and Practice, College of Pharmacy, University of Florida, PO Box 100486, Gainesville, FL, USA.ORCID https://orcid.org/0000-0002-5985-7979
Sara F AzimiDepartment of Pharmacy, Nebraska Medicine, Omaha, NE, USA.ORCID https://orcid.org/0009-0003-6917-3006
Alison M BeielerHarborview Medical Center, Seattle, WA, USA.ORCID https://orcid.org/0000-0002-9411-699X
Laila CastellinoDivision of Infectious Disease and Geographic Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Sara C KellerDivision of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Margaret PertzbornDepartment of Pharmacy, Mayo Clinic Health System-Northwest Wisconsin Region, Eau Claire, WI, USA.ORCID https://orcid.org/0000-0002-9898-7266
Alexandra YamshchikovDivision of Infectious Diseases, University of Rochester Medical Center, Rochester, NY, USA.ORCID https://orcid.org/0009-0002-2558-1027
Leah H YokeVaccine and Infectious Disease Division, Fred Hutch Cancer Center, Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Kathleen YoungDivision of Infectious Diseases, Oregon Health & Science University, Portland, OR, USA.ORCID https://orcid.org/0009-0001-9765-8970
Monica V MahoneyDepartment of Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Outpatient parenteral antimicrobial therapy (OPAT) is a mainstay of clinical infectious diseases practice, and OPAT-related publications continue to be prominent in journals. The objective of this article is to summarize ten clinically important OPAT-related publications from 2024. Design: Narrative review. Methods: Eighty-one articles were found in a literature search, and 56 met inclusion criteria. A survey containing 25 articles was sent to an email listserv of clinicians with OPAT experience. Results: This article summarizes the top 10 OPAT articles published in 2024, based on those survey results. Conclusions: Common themes from the top 10 OPAT articles published in 2024 included OPAT clinician workload, patient perspectives of OPAT, tools for OPAT work, and dalbavancin use.

Identifiers

PMID41562022
PMCPMC12813723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.